Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Essler

Showing results (111-120 of 208) with videos related to

Pageof 21
Sort By:
Circulation. Cardiovascular Imaging|November 19, 2009
Glucose metabolism in the vessel wall correlates with mechanical instability and inflammatory changes in a patient with a growing aneurysm of the abdominal aortaChristian Reeps, Michael W Gee, A Maier, et al.
Oncotargets and Therapy|October 19, 2017
Theranostics in nuclear medicine practiceAnna Yordanova, Elisabeth Eppard, Stefan Kürpig, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 11, 2017
Overall survival and response pattern of castration-resistant metastatic prostate cancer to multiple cycles of radioligand therapy using [<sup>177</sup>Lu]Lu-PSMA-617Hojjat Ahmadzadehfar, Simone Wegen, Anna Yordanova, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 30, 2026
Quantifying the Renal Impact of [<sup>177</sup>Lu]Lu-PSMA-617: A Longitudinal Analysis of Real-World Data from the LUMEN RegistryThomas Büttner, Christian Hoffmann, Markus Essler, et al.
EJNMMI Research|November 30, 2019
Biodistribution and post-therapy dosimetric analysis of [<sup>177</sup>Lu]Lu-DOTA<sup>ZOL</sup> in patients with osteoblastic metastases: first resultsAmbreen Khawar, Elisabeth Eppard, Frank Roesch, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 5, 2010
Imaging of acute and chronic aortic dissection by 18F-FDG PET/CTChristian Reeps, Jaroslav Pelisek, Ralph A Bundschuh, et al.
Nuclear Medicine and Biology|November 12, 2013
²¹³Bi-anti-EGFR radioimmunoconjugates and X-ray irradiation trigger different cell death pathways in squamous cell carcinoma cellsAnja Pickhard, Guido Piontek, Christof Seidl, et al.
Journal of Radiological Protection : Official Journal of the Society for Radiological Protection|February 5, 2019
Radionuclide intake risks in the clinical administration of <sup>223</sup>RaCl<sub>2</sub>Clemens Scholl, Ralph A Bundschuh, Stefan Hirzebruch, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 3, 2016
Predictors of Response to Radioligand Therapy of Metastatic Castrate-Resistant Prostate Cancer with 177Lu-PSMA-617Justin Ferdinandus, Elisabeth Eppard, Florian C Gaertner, et al.
Oncology Letters|January 21, 2017
<sup>18</sup>F-fluoroethyl-L-tyrosine positron emission tomography-guided diagnosis of a malignant intramedullary spinal cord tumorSied Kebir, Okka Kimmich, Pitt Niehusmann, et al.
Pageof 21

Showing results (111-120 of 208) with videos related to

Sort By:
Pageof 21
Circulation. Cardiovascular Imaging|November 19, 2009
Glucose metabolism in the vessel wall correlates with mechanical instability and inflammatory changes in a patient with a growing aneurysm of the abdominal aortaChristian Reeps, Michael W Gee, A Maier, et al.
Oncotargets and Therapy|October 19, 2017
Theranostics in nuclear medicine practiceAnna Yordanova, Elisabeth Eppard, Stefan Kürpig, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 11, 2017
Overall survival and response pattern of castration-resistant metastatic prostate cancer to multiple cycles of radioligand therapy using [<sup>177</sup>Lu]Lu-PSMA-617Hojjat Ahmadzadehfar, Simone Wegen, Anna Yordanova, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 30, 2026
Quantifying the Renal Impact of [<sup>177</sup>Lu]Lu-PSMA-617: A Longitudinal Analysis of Real-World Data from the LUMEN RegistryThomas Büttner, Christian Hoffmann, Markus Essler, et al.
EJNMMI Research|November 30, 2019
Biodistribution and post-therapy dosimetric analysis of [<sup>177</sup>Lu]Lu-DOTA<sup>ZOL</sup> in patients with osteoblastic metastases: first resultsAmbreen Khawar, Elisabeth Eppard, Frank Roesch, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 5, 2010
Imaging of acute and chronic aortic dissection by 18F-FDG PET/CTChristian Reeps, Jaroslav Pelisek, Ralph A Bundschuh, et al.
Nuclear Medicine and Biology|November 12, 2013
²¹³Bi-anti-EGFR radioimmunoconjugates and X-ray irradiation trigger different cell death pathways in squamous cell carcinoma cellsAnja Pickhard, Guido Piontek, Christof Seidl, et al.
Journal of Radiological Protection : Official Journal of the Society for Radiological Protection|February 5, 2019
Radionuclide intake risks in the clinical administration of <sup>223</sup>RaCl<sub>2</sub>Clemens Scholl, Ralph A Bundschuh, Stefan Hirzebruch, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 3, 2016
Predictors of Response to Radioligand Therapy of Metastatic Castrate-Resistant Prostate Cancer with 177Lu-PSMA-617Justin Ferdinandus, Elisabeth Eppard, Florian C Gaertner, et al.
Oncology Letters|January 21, 2017
<sup>18</sup>F-fluoroethyl-L-tyrosine positron emission tomography-guided diagnosis of a malignant intramedullary spinal cord tumorSied Kebir, Okka Kimmich, Pitt Niehusmann, et al.
Pageof 21